Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $46,890 - $52,431
-810 Reduced 1.56%
51,067 $2.96 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $6,753 - $7,498
-106 Reduced 0.2%
51,877 $3.32 Million
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $18,070 - $20,495
-275 Reduced 0.53%
51,983 $3.6 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $46,703 - $55,303
-682 Reduced 1.29%
52,258 $3.76 Million
Q3 2022

Oct 24, 2022

BUY
$0.13 - $76.84 $1 - $768
10 Added 0.02%
52,940 $3.76 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $273,704 - $301,444
-3,769 Reduced 6.65%
52,930 $4.08 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $184 - $221
3 Added 0.01%
56,699 $4.14 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $102,057 - $118,975
-1,903 Reduced 3.25%
56,696 $3.54 Million
Q3 2021

Oct 26, 2021

BUY
$59.17 - $69.31 $422,118 - $494,457
7,134 Added 13.86%
58,599 $3.47 Million
Q2 2021

Jul 20, 2021

SELL
$61.91 - $67.42 $72,620 - $79,083
-1,173 Reduced 2.23%
51,465 $3.44 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $17,327 - $19,488
-292 Reduced 0.55%
52,638 $3.32 Million
Q4 2020

Jan 26, 2021

SELL
$57.74 - $65.43 $61,435 - $69,617
-1,064 Reduced 1.97%
52,930 $3.28 Million
Q3 2020

Oct 21, 2020

SELL
$57.43 - $63.64 $99,353 - $110,097
-1,730 Reduced 3.1%
53,994 $3.26 Million
Q2 2020

Jul 15, 2020

SELL
$54.82 - $64.09 $40,183 - $46,977
-733 Reduced 1.3%
55,724 $3.28 Million
Q1 2020

Apr 21, 2020

BUY
$46.4 - $67.43 $303,734 - $441,396
6,546 Added 13.12%
56,457 $3.15 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $1.9 Million - $2.48 Million
38,654 Added 343.38%
49,911 $3.2 Million
Q3 2019

Oct 30, 2019

SELL
$42.77 - $50.71 $18,519 - $21,957
-433 Reduced 3.7%
11,257 $571,000
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $85,090 - $94,091
1,907 Added 19.49%
11,690 $530,000
Q1 2019

Apr 11, 2019

BUY
$45.12 - $53.8 $441,408 - $526,325
9,783 New
9,783 $466,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Augustine Asset Management Inc Portfolio

Follow Augustine Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Augustine Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Augustine Asset Management Inc with notifications on news.